JUNO


Company Update (NASDAQ:JUNO): Juno Therapeutics Inc Appoints Robert Azelby as Chief Commercial Officer

Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, announced the appointment of …

Trade Like George Soros: Alibaba Group Holding Ltd (BABA), Facebook Inc (FB), Juno Therapeutics Inc (JUNO), Cypress Semiconductor Corporation (CY)

Business magnate and philanthropist George Soros is known for operating one of the most profitable hedge funds, Soros Fund Management LLC. Known as the “Man …

J.P. Morgan Maintains Overweight on Juno Therapeutics Inc Following Investor Meetings

In a research report released today, J.P.

Insider Selling News: Tesla Motors Inc (TSLA), Skyworks Solutions Inc (SWKS), Novavax, Inc. (NVAX), Avago Technologies Ltd (AVGO), Juno Therapeutics Inc (JUNO)

Recently, various executives have taken part in insider selling activity for the stocks of Tesla Motors Inc (NASDAQ:TSLA), Skyworks Solutions Inc (NASDAQ:SWKS), Novavax, Inc. (NASDAQ:NVAX), Avago Technologies Ltd (NASDAQ:AVGO), …

Tuesday’s Morning Insights: Alibaba Group Holding Ltd, Juno Therapeutics Inc, SanDisk Corporation, FireEye Inc

Alibaba Group Holding Ltd (NYSE:BABA) shares slipped -1.6% in pre-market trading down to $73.

Stock Update (NASDAQ:JUNO): Juno Therapeutics Inc Reports 2Q:15 Financial Results

Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today reported business …

Company Update (NASDAQ:JUNO): Juno Therapeutics Inc Announces Early HSR Clearance for Global Collaboration With Celgene

Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced that the …

Juno Therapeutics Inc is a ‘Buying Opportunity’: Maxim

Maxim’s healthcare analyst Jason McCarthy weighed in with some commentary on Juno Therapeutics Inc (NASDAQ:JUNO), after the company announced that FDA has cleared its investigational new drug application for …

Juno Therapeutics Inc (JUNO) Announces FDA Clearance of IND Application for JCAR015 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia

Juno Therapeutics Inc (NASDAQ:JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, today announced the U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts